PhDs and parishioners

In late 2004, Michael Zimmerman, dean of the College of Arts and Sciences and professor of biology at Butler University, was watching early media coverage of the Dover, Pa., intelligent design trial, which broadcast several fundamentalist ministers condemning evolution, and felt frustrated. What he saw was a war between science and religion, and science was losing. So Zimmerman decided to call for a truce. He asked a friend, a member of the clergy, to draft a letter to religious

Written byAndrea Gawrylewski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In late 2004, Michael Zimmerman, dean of the College of Arts and Sciences and professor of biology at Butler University, was watching early media coverage of the Dover, Pa., intelligent design trial, which broadcast several fundamentalist ministers condemning evolution, and felt frustrated. What he saw was a war between science and religion, and science was losing.

So Zimmerman decided to call for a truce. He asked a friend, a member of the clergy, to draft a letter to religious leaders, declaring that science and religion should not be at odds. The letter reads, in part: "We believe that the theory of evolution is a foundational scientific truth, one that has stood up to rigorous scrutiny."

Within a month, 200 clergy members had signed the letter. Over the next year, another 10,000 clergy members throughout the world added their names. Reverend Nancy Rockwell, senior pastor of the Congregational Church in Exeter, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies